Erratum to: Invest New Drugs
DOI 10.1007/s10637-016-0401-4
Due to a formatting error, the name of one of the authors, Simone dos Santos Aguiar, appeared as Simone Santos dos Aguiar. The correct authors’ name is as shown above. The original article was corrected.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s10637-016-0401-4.
Rights and permissions
About this article
Cite this article
Andrade, A.F., Borges, K.S., Suazo, V.K. et al. Erratum to: The DNA methyltransferase inhibitor zebularine exerts antitumor effects and reveals BATF2 as a poor prognostic marker for childhood medulloblastoma. Invest New Drugs 35, 124 (2017). https://doi.org/10.1007/s10637-016-0412-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10637-016-0412-1